Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexander Roeth is active.

Publication


Featured researches published by Alexander Roeth.


Blood | 2012

Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results

Elisabeth Oppliger Leibundgut; Christina Ayran; Martha Blaney; Bart Burington; Dianne Morfeld; Olatoyosi Odenike; Oliver Ottman; Anita Reddy; Alexander Roeth; Gary Spitzer; Monic J. Stuart; Srdan Verstovsek; David S. Snyder


Blood | 2012

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Gerald Illerhaus; Kristina Fritsch; Gerlinde Egerer; Monika Lamprecht; Nikolas von Bubnoff; Hans-Heinrich Wolf; Gottfried Dölken; Stephan Stilgenbauer; Jens Panse; Stefan Balabanov; Peter Hau; Norbert Frickhofen; Martin Bentz; Alexander Roeth; Robert Möhle; Tobias Birnbaum; Michael Pfreundschuh; Claudia Hader; Gabriele Ihorst; Martina Deckert; Marco Prinz; Elisabeth Schorb; Heidi Fricker; Benjamin Kasenda; Jürgen Finke


Journal of Clinical Oncology | 2011

Prognostic factors for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide: Results from a German phase III trial (G-PCNSL-SG-1).

Peter Martus; Kristoph Jahnke; Agnieszka Korfel; T. Rose; Lars Fischer; Robert Moehle; H. A. Klasen; Michael Rauch; Alexander Roeth; Bernd Hertenstein; Thomas Fischer; Thomas Hundsberger; Hans-Guenther Mergenthaler; Malte Leithäuser; Tobias Birnbaum; Ulrich Herrlinger; J. Schubert; J. Birkmann; Michael Weller; Eckhard Thiel


Blood | 2017

Optimization of Dose Regimen for ALXN1210, a Novel Complement C5 Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results of 2 Phase 1/2 Studies

Alexander Roeth; Scott T. Rottinghaus; Anita Hill; Jin Seok Kim; Hubert Schrezenmeier; Louis Terriou; Alvaro Urbano-Ispizua; Richard A. Wells; Jun Ho Jang; Jeff Szer; Rasha Aguzzi; Eric Bachman; Andrew I. Damokosh; Lori Shafner; Jong-Wook Lee


Blood | 2012

Long-Term Safety of Sustained Eculizumab Treatment in Patients with Paroxysmal Nocturnal Hemoglobinuria

Jeff Szer; Petra Muus; Alexander Roeth; Modupe Elebute; Antonio M. Risitano; Hubert Schrezenmeier; Jaroslaw P. Maciejewski; Alvaro Urbano-Ispizua; Carlos M. de Castro; Gérard Socié; Robert A. Brodsky


Blood | 2017

The SMART-IgG Anti-hC5 Antibody (SKY59/RO7112689) Has Favorable PK, PD, Subcutaneous Bioavailability, and Safety Profile in Phase I HV Study

Alexander Roeth; Nagy Zsolt; Miklós Egyed; Erica Winter; Joy Hsu; Andreas Dieckmann; Judith Anzures-Cabrera; Marie Mannino; Elana Fernandez; Gregor Jordan; Barbara Klughammer; Kenji Shinomiya; Naoki Kotani; Ido Paz-Priel; Angelika Jahreis


Blood | 2015

Dynamics of mutations in patients with ET treated with Imetelstat

Elisabeth Oppliger Leibundgut; Monika Haubitz; Bart Burington; Oliver G. Ottmann; Gary Spitzer; Olatoyosi Odenike; Michael A. McDevitt; Alexander Roeth; David S. Snyder


Journal of Clinical Oncology | 2014

G-PCNSL-SG-1 randomized phase III trial of high-dose methotrexate with or without whole brain radiotherapy for primary central nervous system lymphoma: Long-term follow-up.

Agnieszka Korfel; Eckhard Thiel; Peter Martus; Robert Moehle; Frank Griesinger; Michael Rauch; Alexander Roeth; Bernd Hertenstein; Thomas Fischer; Thomas Hundsberger; Hans-Guenther Mergenthaler; Christian Junghanss; Tobias Birnbaum; Lars Fischer; Kristoph Jahnke; Ulrich Herrlinger; Ludwig Plasswilm; Thomas Naegele; Torsten Pietsch; Michael Weller


Blood | 2013

Development Of a Disease Specific Quality Of Life Questionnaire For Patients With Aplastic Anemia and/Or Paroxysmal Nocturnal Hemoglobinuria (QLQ-AA/PNH)

Susanne Singer; Cathrin Niedeggen; Andrea Petermann-Meyer; Alexander Roeth; Hubert Schrezenmeier; Britta Höchsmann; Tim H. Brümmendorf; Jens Panse


Journal of Clinical Oncology | 2011

Impact of meningeal dissemination (MD) on outcome in primary CNS lymphoma in the G-PCNSL-SG1 trial

Agnieszka Korfel; Lars Fischer; Peter Martus; Robert Moehle; H. A. Klasen; Michael Rauch; Alexander Roeth; Bernd Hertenstein; Thomas Fischer; Hans-Guenther Mergenthaler; Thomas Hundsberger; Malte Leithäuser; Tobias Birnbaum; A. Florschütz; Kristoph Jahnke; Ulrich Herrlinger; Michael Weller; Eckhard Thiel

Collaboration


Dive into the Alexander Roeth's collaboration.

Top Co-Authors

Avatar

Peter Martus

University of Tübingen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ulrich Duehrsen

University of Duisburg-Essen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas Fischer

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge